Get the Weekly Intelligence Brief — top committee picks every Sunday.
ORCL · NYSE · STOCK

Oracle (ORCL) Stock Analysis

Technology Updated August 23, 2026
$146.47
52W $114.50 – $345.72
57/100
$421.90B
24.7
1.72
AI Committee Verdict
Buy
57/100
Conviction: Contested · 50% agreement · 6 analysts
+17.2%
-7.7%
2.25:1
Contested

Is ORCL Bullish or Bearish?

Bullish. Innellis AI committee rates Oracle Corporation (ORCL) Buy with a composite score of 57/100 , based on 6 analysts with 50% agreement. Last updated August 23, 2026.

What Would Change This View

Upgrade to Strong Buy
Requires a committee score of 75.0 — +18.46 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Watch
Requires the score to fall below 55.0 — -1.54 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The committee is genuinely divided. Growth Analyst sees a compelling case — eps growing 35.0% yoy. Risk Analyst remains cautious — high leverage (debt-to-equity 3.01) amplifies downside in a stress scenario. This disagreement is itself the signal — the setup is not clean in either direction.

Bull & Bear Case

Bull Case
  • ROE of 50.4% shows genuine earnings power backing the valuation — Value
  • EPS growing 35.0% YoY — Growth
  • 3 consecutive earnings beats -- consistent execution — Growth
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • MACD histogram positive -- bullish momentum — Technical
Bear Case
  • P/E of 26.4 is moderate-to-rich — Value
  • Price-to-book of 16.6x prices in significant intangible value — Value
  • Debt-to-equity of 3.01 adds balance-sheet risk to the value case — Value
  • High leverage (debt-to-equity 3.01) amplifies downside in a stress scenario — Risk
  • Bollinger bandwidth of 32.4% signals elevated volatility — Risk
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of August 23, 2026
Overall Committee Score
57/100
Agreement
50%
Analysts
6
Conviction
Contested
Sector Rank
Top 60%
of 287 Technology peers
Value Analyst neutral
45 / 100 · High confidence
Fair value -- neither a bargain nor obviously overpriced
+ ROE of 50.4% shows genuine earnings power backing the valuation
− P/E of 26.4 is moderate-to-rich
Growth Analyst bullish
79 / 100 · High confidence
Strong, accelerating growth with consistent execution
+ EPS growing 35.0% YoY
Technical Analyst neutral
58 / 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
Risk Analyst bearish
32 / 100 · Moderate confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− High leverage (debt-to-equity 3.01) amplifies downside in a stress scenario
Macro Analyst bullish
65 / 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst neutral
60 / 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
Portfolio Manager neutral
45 / 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 3069.37)
Open Full Terminal →

Investment Thesis Evolution

Committee score moved marginally from 56.5 to 56.5.

Comparing 2026-08-22 to 2026-08-23 (1 day apart).

Technical Analysis

RSI (14)
54.7
Neutral
MACD Histogram
0.875
Bullish Momentum
Trend Direction
Sideways
Weekly: Uptrend
Market Structure
Mixed
Support
$135.27
Resistance
$171.73
Bollinger %B
0.62
Inside Bands
Price vs Moving Averages
EMA 9
$145.29 Above
EMA 21
$143.19 Above
EMA 50
$148.71 Below
EMA 200
$172.17 Below

Fundamental Analysis

Valuation
54
Growth
92
Profitability
91
Financial Health
13
Cash Flow
15
Valuation
P/E Ratio 24.7×
P/B Ratio 9.92×
PEG Ratio 0.74
Dividend Yield 1.37%
52W High $345.72
52W Low $114.50
Quality & Growth
ROE 4019.7%
ROA 652.8%
Gross Margin 6581.1%
Operating Margin 3084.7%
Revenue Growth YoY
Debt / Equity 3.67
AI Fundamental Assessment
P/E ratio of 24.7 (inexpensive relative to a 15-40x range); Price-to-book of 9.9x; PEG ratio of 0.7 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 40.2%; Return on assets of 6.5%; Net margin of 25.4%; Gross margin of 65.8%; Current ratio of 1.12 (tight short-term liquidity); Debt-to-equity of 3.67; Free cash flow per share is negative (-8.23); Most recent quarter beat estimates by 1.4%; 3 consecutive earnings beats; EPS growth accelerating (-20.8% -> +13.4% QoQ); Analyst estimates rising over recent quarters
Get the Full ORCL Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime